Macmaster JF - Search Results

1

Wallace PM, Macmaster JF, Rillema JR, Rouleau KA, Hanson MB, Burstein SA, Shoyab M. Wallace PM, et al. Among authors: macmaster jf. Ann N Y Acad Sci. 1995 Jul 21;762:42-54. doi: 10.1111/j.1749-6632.1995.tb32313.x. Ann N Y Acad Sci. 1995. PMID: 7545375 Review. No abstract available.

2

Thrombocytopoietic properties of oncostatin M.

Wallace PM, MacMaster JF, Rillema JR, Peng J, Burstein SA, Shoyab M. Wallace PM, et al. Among authors: macmaster jf. Blood. 1995 Aug 15;86(4):1310-5. Blood. 1995. PMID: 7632937 Free article.

3

Regulation of inflammatory responses by oncostatin M.

Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, Wahl AF. Wallace PM, et al. Among authors: macmaster jf. J Immunol. 1999 May 1;162(9):5547-55. J Immunol. 1999. PMID: 10228036

4

In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.

Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM. Svensson HP, et al. Among authors: macmaster jf. Cancer Res. 1995 Jun 1;55(11):2357-65. Cancer Res. 1995. PMID: 7757987

5

Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.

Wallace PM, MacMaster JF, Smith VF, Kerr DE, Senter PD, Cosand WL. Wallace PM, et al. Among authors: macmaster jf. Cancer Res. 1994 May 15;54(10):2719-23. Cancer Res. 1994. PMID: 8168103

6

CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers.

Wallace PM, Johnson JS, MacMaster JF, Kennedy KA, Gladstone P, Linsley PS. Wallace PM, et al. Among authors: macmaster jf. Transplantation. 1994 Sep 15;58(5):602-10. doi: 10.1097/00007890-199409150-00013. Transplantation. 1994. PMID: 8091487

7

Oncostatin M: development of a pleiotropic cytokine.

Loy JK, Davidson TJ, Berry KK, Macmaster JF, Danle B, Durham SK. Loy JK, et al. Among authors: macmaster jf. Toxicol Pathol. 1999 Mar-Apr;27(2):151-5. doi: 10.1177/019262339902700201. Toxicol Pathol. 1999. PMID: 10207978 Review.

8

Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.

Dhar TG, Shen Z, Guo J, Liu C, Watterson SH, Gu HH, Pitts WJ, Fleener CA, Rouleau KA, Sherbina NZ, McIntyre KW, Shuster DJ, Witmer MR, Tredup JA, Chen BC, Zhao R, Bednarz MS, Cheney DL, MacMaster JF, Miller LM, Berry KK, Harper TW, Barrish JC, Hollenbaugh DL, Iwanowicz EJ. Dhar TG, et al. Among authors: macmaster jf. J Med Chem. 2002 May 23;45(11):2127-30. doi: 10.1021/jm0105777. J Med Chem. 2002. PMID: 12014950

9

Reductively activated disulfide prodrugs of paclitaxel.

Vrudhula VM, MacMaster JF, Li Z, Kerr DE, Senter PD. Vrudhula VM, et al. Among authors: macmaster jf. Bioorg Med Chem Lett. 2002 Dec 16;12(24):3591-4. doi: 10.1016/s0960-894x(02)00784-9. Bioorg Med Chem Lett. 2002. PMID: 12443783

10

An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice.

MacMaster JF, Dambach DM, Lee DB, Berry KK, Qiu Y, Zusi FC, Burke JR. MacMaster JF, et al. Inflamm Res. 2003 Dec;52(12):508-11. doi: 10.1007/s00011-003-1206-4. Epub 2003 Nov 13. Inflamm Res. 2003. PMID: 14991079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters